THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks Rank #2 (Buy) company boasts a pipeline of differentiated therapies across a ...

View Atara Biotherapeutics Inc ATRA stock quote prices, financial information, real-time forecasts, and company news from CNN.

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

To solve the FDA-identified problems, Atara stated it is collaborating with third-party manufacturer and partner Pierre Fabre Laboratories. With a possible approval period of six months after ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

Based on promising results from the Phase 1a study including sustained disability improvements among progressive MS patients, the Phase 1b study will assess clinical outcomes including measures of ...

Atara Biotherapeutics (NASDAQ:ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD). The ...

While it may not be enough for some shareholders, we think it is good to see the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) share price up 19% in a single quarter. Meanwhile over the last three years ...

Shares of the next-generation cell therapy company Atara Biotherapeutics (ATRA 1.86%) are getting hammered today. Specifically, the clinical-stage biotech's stock was down by an unsightly 54% as of ...

Atara Biotherapeutics Inc. Annual stock financials by MarketWatch. View the latest ATRA financial statements, income statements and financial ratios.

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is ...